Jim Cramer Says He Has ‘Tremendous Faith’ Walgreens Boots Alliance, Inc. (WBA) CEO Tim Wentworth
We recently published an article titled Jim Cramer Discussed These 7 Stocks. In this article, we are going to take a look at ...
Jim Cramer says Nvidia's pullback could be a good chance to buy
CNBC’s Jim Cramer extolled Nvidia’s stock and reviewed its Tuesday action, saying the decline was unrelated to the company ...
Jim Cramer's four big-picture questions for 2025
CNBC’s Jim Cramer on Friday opined on the uncertainty of 2025 and listed four of the most pressing macroeconomic questions he ...
Jim Cramer on Constellation Brands, Inc. (STZ): ‘It’s A Bit Of A Jobe Stock’
We recently published an article titled Jim Cramer Discussed These 7 Stocks. In this article, we are going to take a look at ...
Insider Monkey on MSN3h
Jim Cramer Says Delta Air Lines, Inc. (DAL) Is ‘A Changed Breed’
We recently published an article titled Jim Cramer Discussed These 7 Stocks. In this article, we are going to take a look at ...
Jim Cramer urges investors to sell volatile stocks in quantum computing: ‘I can't be part of this froth'
CNBC’s Jim Cramer on Wednesday told investors to be wary of market froth, especially volatile stocks related to quantum ...
Jim Cramer opines on TikTok ban: ‘Let's just call it anybody's ballgame'
The Supreme Court is set to hear TikTok's appeal on Friday, and Cramer said it's "anybody's ballgame," since the issue isn't ...
Jim Cramer looks ahead to Friday's employment data: ‘We're at the mercy of macro numbers'
Reviewing Tuesday's market-wide decline, CNBC's Jim Cramer attributed much of the pullback to investors' worries about ...
MicroStrategy (MSTR): Jim Cramer Doubts Bitcoin-Driven Growth After 359% Surge
We recently published a list of Jim Cramer Discussed These 10 NASDAQ 100 Stocks Recently. In this article, we are going to ...
Jim Cramer Sees Buying Opportunity In Nvidia But Attributes 6% Fall To 'Too Much Hot Money' After Jensen Huang's CES Keynote
Jim Cramer urged investors to consider NVIDIA Corp.'s recent stock decline as a buying opportunity, despite the company's ...
Jim Cramer: Lemonade Is 'Up Too Much,' This Health Care Stock Can Go Lower
JMP Securities analyst Ronald Josey maintained Lemonade with a Market Outperform and raised the price target from $40 to $60.